TRANSFORMED FOLLICULAR LYMPHOMA
Clinical trials for TRANSFORMED FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to keep lymphoma in check after CAR-T treatment
Disease control Not yet recruitingThis study tests whether the drug pirtobrutinib can help prevent relapse in people with B-cell lymphoma who have already received CAR-T cell therapy. Twenty adults will take pirtobrutinib daily for six months after their CAR-T infusion. The main goal is to see how many achieve a …
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 24, 2026 03:03 UTC
-
Can we track lymphoma in real time? new study aims to find out
Knowledge-focused Not yet recruitingThis study tests whether doctors can monitor minimal residual disease (tiny amounts of cancer left after treatment) in aggressive B-cell lymphoma patients using blood tests and PET scans in real time. About 129 participants will provide blood samples before, during, and after tre…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA
Sponsor: The Lymphoma Academic Research Organisation • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:57 UTC